Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.86 EUR | +0.11% |
|
-0.45% | -29.69% |
May. 08 | Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024 | CI |
Apr. 29 | Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024 |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company is in a robust financial situation considering its net cash and margin position.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- With an enterprise value anticipated at 4.23 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.69% | 264M | - | ||
+20.72% | 3,374B | C+ | ||
+19.63% | 94.38B | B | ||
+15.88% | 86.53B | B+ | ||
+66.98% | 63.85B | D+ | ||
-22.48% | 49.62B | B+ | ||
+39.09% | 48.96B | D+ | ||
-24.35% | 46.84B | B- | ||
+77.46% | 41.28B | D+ | ||
-4.75% | 26.83B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- REMEDY Stock
- Ratings Remedy Entertainment Oyj